Previous Close | 0.54 |
1-Year Change | 28.57% |
6-Months Change | -34.94% |
3-Months Change | -8.47% |
Moving Avg (50d) | 0.7087 |
Moving Avg (200d) | 0.8598 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 79.0M |
Beta (3-Years) | 0.95 |
Revenue Growth (ttm) | -3.07% |
Net Profit Margin (ttm) | -249.15% |
Return On Assets (ttm) | -96.59% |
EPS (ttm) | -0.27 |
PE Ratio (ttm) | -2 |
Dividend Yield | % |
Asset Description: | Veru Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.551 | 0.567 | 0.578 | 0.594 | 0.621 | 0.648 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |